No spam - just the good stuff

Subscribe to our newsletter
Hidden
  • News
  • Investment
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
Posted on May 19, 2023May 23, 2023

Ani Biome and Deep Longevity collaborate to build personalized care tools for longevity

Improving gut health, immunity and longevity by combining the power of fermentation with the power of AI. Ani Biome, a …

Continue reading “Ani Biome and Deep Longevity collaborate to build personalized care tools for longevity”

Posted on July 8, 2022March 1, 2023

Deep Longevity bags the first microbiomic aging clock patent

New patent describes tech for creation of antiaging diets and probiotic treatments. The neural network that can estimate the age …

Continue reading “Deep Longevity bags the first microbiomic aging clock patent”

Posted on March 31, 2022May 10, 2022

Deep Longevity – extending longevity and increasing human performance

Deep Longevity – on a mission to extend healthy productive longevity and increase human performance. Over the coming weeks, we …

Continue reading “Deep Longevity – extending longevity and increasing human performance”

Posted on May 18, 2021December 9, 2022

Deep Longevity to partner with LifeHub & LifeClinic

Deep Longevity adds LifeHub & LifeClinic to its growing longevity network, with physicians trained to interpret Deep Longevity’s biological age reports …

Continue reading “Deep Longevity to partner with LifeHub & LifeClinic”

Posted on December 15, 2020October 14, 2022

Regent Pacific completes acquisition of Deep Longevity

The Hong Kong group has acquired the Longevity AI and aging clock specialist Deep Longevity. In a move that cements …

Continue reading “Regent Pacific completes acquisition of Deep Longevity”

Posted on December 9, 2020October 14, 2022

Deep Longevity reveals highly-accurate aging clock

Epigenetic aging clock DeepMAge has 3-year error margin and could be the most accurate DNA methylation clock to date. Deep …

Continue reading “Deep Longevity reveals highly-accurate aging clock”

Posted on October 23, 2020October 14, 2022

Deep Longevity and Longenesis collaborate to clock aging

Start the clock to stop the clock – centralised data will aid Longevity research.  Deep Longevity, which engages in the …

Continue reading “Deep Longevity and Longenesis collaborate to clock aging”

Posted on September 2, 2020December 7, 2022

Deep Longevity acquired by Regent Pacific

Hong Kong public company enters Longevity business by acquiring aging clock specialist Deep Longevity. Not even two months after it …

Continue reading “Deep Longevity acquired by Regent Pacific”

Posted on July 14, 2020October 14, 2022

Deep Longevity exits stealth to partner with HLI

Insilico announces Deep Longevity, a spin-out that will collaborate with Human Longevity Inc. to deploy an extensive range of AI-powered …

Continue reading “Deep Longevity exits stealth to partner with HLI”

Posts navigation

Page 1 Page 2 … Page 5 Next page

Find us here ...

Subscribe to our newsletter

Hidden

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.